Hanzel J, Zdovc J, Kurent T, Sever N, et al. Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn's Disease Likely to Achieve Endoscopic and Biochemical Remission. Clin Gastroenterol Hepatol 2021;19:111-118.
PMID: 32109630